课题基金 / 基金详情

Genetic Determinants of Bone Fragility

Genetic Determinants of Bone Fragility
骨脆性的遗传决定因素
批准号:
7901195
负责人:
Michael J Econs
金额:
$12.32万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-08-15 至 2010-07-31

项目摘要

项目成果

Michael J Econs的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Age-related osteoporotic fractures are largely due to an increased propensity to fall and an increase in bone fragility due to a reduction in bone strength with aging. Several factors contribute to bone strength including bone mineral density (BMD), bone structure, and bone quality, all of which have phenotypes that are highly heritable. During the tenure of the current award we have identified several highly promising chromosomal regions that contain genes that influence peak bone strength in white and black American men and women and in rats. The goal of this application is to further define QTL that are linked to phenotypes of peak bone strength, identify which QTL are sex-specific, and to identify genes that underlie bone fragility using the combined positional cloning/candidate gene approach. It is expected that these proposed studies will greatly contribute to our understanding of the reasons for the higher risk of osteoporotic fracture in women than men and in American whites than blacks. Furthermore, identification of these genes may: 1) lead to molecular tests that predict the risk of osteoporosis, thereby allowing the early institution of preventive measures; 2) provide insight into the basic skeletal biology that underlies bone fragility and the predisposition to fracture; and 3) identify molecular targets for the development of therapeutic agents aimed at increasing bone strength.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of Tmem263 in regulation of bone mass and strength
Mechanistic Ancillary Study to the Natural History Study of ADO2 to Determine Clinical Severity
The role of Tmem263 in regulation of bone mass and strength
The Natural History of Autosomal Dominant Osteopetrosis Type 2
海外基金